Monitoring of a patient who is on a lipid-lowering drug includes:
1. Fasting total cholesterol every 6 months
2. Lipid profile with attention to serum LDL 6 to 8 weeks after starting therapy, then again in 6 weeks
3. Complete blood count, C-reactive protein, and erythrocyte sedimentation rate after 6 weeks of therapy
4. All of the above
Question 2
Joanne is a 60-year-old patient with an LDL of 132 and a family history of coronary artery disease. She has already tried diet changes (increased fiber and plant sterols) to lower her LDL and after 6 months her LDL is slightly higher.
The next step in her treatment would be:
1. A statin
2. Niacin
3. Sterols
4. A fibric acid derivative
Building competency in patient centered care
Patient Teaching Methods Cont.
Different routes of parenteral drug administration.
Common Cytochrome P450 Drug Interactions in Dentistry